Geraldine is an investor at The Engine, launched by MIT to invest in early-stage Tough Tech companies and accelerate their path to market through a combination of capital, infrastructure and network. She is excited about breakthrough new technologies spanning all the way from quantum to agtech to advanced manufacturing and more. Mostly she loves working with talented and mission-driven founders who want to make a positive impact on the world through science and technology.
Geraldine brings over a decade of academic experience, with a strong focus on translational and cross-disciplinary research in chemical engineering and biology. Her doctoral work at MIT focused on photovoltaics, nano-electronics, and biosensors using graphene and carbon nanotubes. As a postdoctoral researcher at MGH and The Broad Institute, she applied CRISPR technology to autophagy and immunology, towards the development of therapeutics.